Cardiogen
AEDR | Cardiovascular Bioregulator Peptide
Cardiogen is a Khavinson bioregulator peptide consisting of four amino acids, derived from heart tissue research. Unlike larger peptides that work on cell surfaces, Cardiogen penetrates directly to the cell nucleus where it binds to specific DNA regions to regulate gene expression. This epigenetic mechanism supports tissue repair and improves cardiovascular function, particularly benefiting the heart and blood vessels.
Mechanism of Action
Cardiogen works through epigenetic regulation by penetrating cell nuclei and interacting with specific DNA regions, histones, and nucleosomes. It regulates which genes are activated or suppressed without changing DNA sequence. This mechanism supports cardiac tissue repair, enhances myocardial function, and improves cardiovascular tissue regeneration by influencing gene expression in heart cells.
Key Benefits
- Supports cardiac tissue repair and regeneration
- Regulates cardiovascular gene expression
- Improves myocardial function
- May support post-cardiac event recovery
- Epigenetic mechanism for targeted action
- Works at DNA/nuclear level
- Part of comprehensive anti-aging protocols
- Well-researched Khavinson peptide
AEDRAlanine
Position 1
Glutamic Acid
Position 2
Aspartic Acid
Position 3
Arginine
Position 4
Cardiovascular Support
- Cardiac Tissue Repair
Supports heart tissue repair through gene expression regulation at the nuclear level.
- Myocardial Function
May improve overall myocardial function and cardiac performance.
- Cardiovascular Aging
Addresses age-related cardiovascular decline through bioregulation.
Anti-Aging
- Epigenetic Regulation
Influences gene expression to support tissue repair without altering DNA sequence.
- Tissue Regeneration
Promotes cardiac tissue regeneration at the cellular level.
Available in capsule form for oral administration. Short peptides can be absorbed orally and reach target tissues. Typical protocol involves 10-20 day cycles, often repeated 2-3 times per year.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Standard protocol | 10-20 mg | Daily for 10-20 days | Oral capsules |
| Maintenance | 10 mg | 2-3 cycles yearly | Oral capsules |
Complementary cardiovascular bioregulators - Cardiogen for heart, Vesugen for vessels.
Often combined in comprehensive anti-aging Khavinson protocols.
Different organ targets; can be used in comprehensive bioregulator protocols.
Part of Khavinson bioregulator family; targets different tissue.
Gene expression modulation begins
Effects persist due to epigenetic changes
Cardiovascular function improvements
Cumulative benefits with periodic cycles
Common Side Effects
- Generally well-tolerated
- Minimal side effects reported
Stop Signs - Discontinue if:
- Allergic reactions
- Unusual cardiac symptoms
Contraindications
- Active cardiac emergencies (seek medical care)
- Known hypersensitivity
- Pregnancy or breastfeeding
Good Signs
- White powder or capsules
- Clear solution if reconstituted
- Proper packaging and labeling
Warning Signs
- Unknown source or purity
Bad Signs
- Discoloration
- Unusual odor
- Damaged packaging
- Peptide Regulation of Gene Expression: A Systematic ReviewMolecules (MDPI) (2021)
Short peptides can penetrate nuclei, interact with DNA and histones to regulate gene expression.
- Cardiogen Bioregulator ResearchBulletin of Experimental Biology and Medicine (2015)
Demonstrated effects on cardiac tissue through gene expression modulation.
- Khavinson Peptide Bioregulators OverviewAdvances in Gerontology (2020)
Comprehensive review of bioregulator peptides and their epigenetic mechanisms.
Disclaimer
This information is for educational and research purposes only. Consult a healthcare professional before use.